Financials
| September Quarterly Activities and Cash Flow | Oct. 31, 2022 |
| 2022 AGM Notice of Meeting and Annual Report | Oct. 18, 2022 |
| Annual Financial Report | Oct. 03, 2022 |
| Preliminary Financial Report for 30 June 2022 | Sep. 01, 2022 |
| Interim Financial Report | Mar. 01, 2022 |
| September 2021 Quarterly Report & Cash Flow | Oct. 26, 2021 |
| Annual Financial Report | Sep. 30, 2021 |
Proxies
| Results of Shareholder’s Annual General Meeting | Nov. 30, 2023 |
| Dispatch of Annual General Meeting Documents | Oct. 31, 2023 |
| Result of AGM and Investor Presentation | Nov. 28, 2022 |
| Notice of AGM | Nov. 16, 2022 |
| Result of AGM | Nov. 25, 2021 |
| Annual General Meeting Webinar Information | Nov. 19, 2021 |
| Dispatch of Annual General Meeting Documents | Oct. 25, 2021 |
Ownership Update
| PDMR Notification | Mar. 28, 2024 |
| Director/PDMR Shareholding | Jan. 11, 2024 |
| Holding(s) in Company | Nov. 16, 2023 |
| Holding(s) in Company | Nov. 13, 2023 |
| Holding(s) in Company | Nov. 09, 2023 |
| Holding(s) in Company | Nov. 08, 2023 |
| Share Purchase Plan Closed | Aug. 30, 2023 |
Announcements
| Change of name to Argent BioPharma Limited | Apr. 02, 2024 |
| Refinancing of Convertible Securities Agreement | Mar. 28, 2024 |
| Results of General Meeting | Mar. 18, 2024 |
| Update - Application for Admission to Trading | Feb. 19, 2024 |
| Dispatch of General Meeting Documents | Feb. 13, 2024 |
| Application for Admission to Trading | Feb. 13, 2024 |
| December 2023 Quarter Activity Report | Jan. 31, 2024 |
Prospectuses
| MGC Pharmaceuticals Limited - Single prospectus | Feb. 04, 2021 |